Sigyn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	0.01	0.01	0.34	0.08	0	0.01	0.01	0.15	0.64	0
Cash & Cash Equivalents	0.01	0.01	0.34	0.08	0	0.01	0.01	0.15	0.64	0
Cash Growth	39.90%	-97.55%	303.97%	16780.40%	-93.33%	-21.84%	-93.59%	-76.58%	672346.32%	-
Receivables	0	0	0	0	0	0	0.01	0	0	0.01
Inventory	0.05	0.05	0.05	0.59	0.59	0.72	0.73	0.72	0.51	0.42
Other Current Assets	0.06	0.01	0	0	0	0	0.02	0	0.01	0.05
Total Current Assets	0.12	0.07	0.39	0.67	0.59	0.73	0.76	0.87	1.16	0.48
Property, Plant & Equipment	0.18	0.24	0.29	0	0	0.02	0.03	0.04	0	0
Goodwill	0	0	0	0	0	0	0.48	0.48	0	0
Intangible Assets	0	0	0.01	0.02	0.05	0.11	0.8	0.95	0.26	0
Other Long-Term Assets	0.02	0.02	0.02	0	0	0	0	0	0	0.08
Total Long-Term Assets	0.2	0.26	0.32	0.02	0.05	0.13	1.31	1.47	0.26	0.08
Total Assets	0.32	0.33	0.71	0.69	0.64	0.86	2.07	2.34	1.43	0.56
Accounts Payable	0.46	0.33	0.04	0.02	0.01	0.02	0.19	0.03	0.4	0
Deferred Revenue	0.87	0	0	0.06	1.17	0.02	0.08	0.08	0	0
Current Debt	2.27	1.69	0.69	0.52	1.9	1.84	1.23	0.59	0	0
Other Current Liabilities	0	0.03	0	0	0.03	2.7	2.66	2.3	1.1	0.46
Total Current Liabilities	3.61	2.05	0.73	0.59	3.1	4.58	4.16	3	1.5	0.46
Long-Term Debt	0.13	0.19	0.24	0	0	0	0	0.03	0.01	0
Other Long-Term Liabilities	0	0	0	0	0	1.86	1.51	0	0	0
Total Long-Term Liabilities	0.13	0.19	0.24	0	0	1.86	1.51	0.03	0.01	0
Total Liabilities	3.73	2.24	0.97	0.59	3.1	4.58	4.16	3.03	1.51	0.46
Total Debt	2.4	1.88	0.93	0.52	1.9	1.84	1.23	0.62	0.01	0
Debt Growth	27.72%	101.01%	80.06%	-72.70%	3.51%	49.01%	98.84%	4819.55%	-	-
Common Stock	0	0	0	0	0.01	0.01	0.01	0	0	0
Retained Earnings	-11.34	-7.2	-4.27	-1.26	-16.08	-13	-10.38	-6.13	-3.33	-0.63
Comprehensive Income	0	0	0	-0	-0	0	0	0	0	0
Shareholders' Equity	-3.41	-1.9	-0.26	0.1	-2.46	-3.72	-2.09	-0.69	-0.08	0.1
Total Liabilities and Equity	0.32	0.33	0.71	0.69	0.64	0.86	2.07	2.34	1.43	0.56
Net Cash / Debt	-2.39	-1.87	-0.59	-0.43	-1.9	-1.83	-1.22	-0.47	0.63	0
Net Cash / Debt Growth	-	-	-	-	-	-	-	-	659092.63%	-
Net Cash Per Share	-2.17	-0.05	-0.02	-0.06	-3.51	-4.21	-3.89	-64.93	2.74	0.00
Working Capital	-3.49	-1.98	-0.34	0.08	-2.51	-3.84	-3.4	-2.13	-0.33	0.02
Book Value Per Share	-3.10	-0.05	-0.01	0.01	-4.54	-8.56	-6.67	-95.61	-0.36	0.53

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.